Busted Biotech Stocks: Where Do We Go From Here?…Updates
4/17/18 Latest portfolio changes are working: CELG at $88, XBI at $84. all based on technicals. ========== Busted Biotech Stocks Get No Help From the Overall Market 4/8 Update XBI down 3% on 4/6 and BELOW SMA 20 AT $82.90. Bellwether Mid-Caps red screen-two up stocks CLVS ICPT ; NKTR down 7.48%...
2018 Large Cap Biopharmaceutical Stocks : First Quarter Performance Update
2018 Large Cap Biopharmaceuticals - Performance Compared to ETFs It has been a rough start for large cap biopharmaceutical stocks but the ETFs (FBT) and (XBI) still outperformed the SPY YTD and over 12 months. Most Individual stocks lagged unless you owned Abbvie (ABBV) or Vertex...
Rayno BioBeat #3…Biotech Bull Market Intact Despite Shaky Start… Update-1
4/2/18 12:30P Update Biotechs break through 2018 support levels with XBI now needs to hold December lows at $80. IBB at double bottom hit in November/December at $102 level. Watch Mid-Cap list below for sector weakness. ============== Biotech Bull Market Is Intact with Unusual Volatility...
Market Rout: Biotechs Busted In Turmoil From Tariffs…Updates
Sell-Off Gets Scary--NASDAQ Futures Still Down at 1:30A EDT 3/28 Double Bottom -Double Top on XBI and Testing February Lows at $87 Another Sell-Off=Tuesday Movers 3/27/18 Large Caps % Up-NONE FBT Down 3.23%, IBB Down 2.77% to $105.12, QQQ down 3.24%, XBI down 4.27% Mid-caps % Up -None...
Biotech Green Day Despite Tech Turmoil: Good Tape Action…Update-2 ABBV
Update-2...3/22 ABBV News Kills Momentum of Biotech Stocks 12:30P EDT Abbvie (ABBV) down 13.5 % on disappointing results on blood cancer drug. The big issue is that the drug was recently acquired for $5.8B from Stemcentrx back in 2016. The Company will not seek accelerated approval for Rova-T...